APIM
MED icon

Agate Pass Investment Management’s Medifast MED Stock Holding History

Agate Pass Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,094
Closed -$735K – 95
2023
Q1 		$735K Buy
7,094
+249
+4% +$27.6K 0.48% 53
2022
Q4 		$790K Sell
6,845
-210
-3% -$24.5K 0.56% 50
2022
Q3 		$764K Sell
7,055
-248
-3% -$35.5K 0.58% 46
2022
Q2 		$1.32M Buy
7,303
+427
+6% +$76.4K 0.93% 35
2022
Q1 		$1.17M Buy
6,876
+378
+6% +$71.3K 0.73% 43
2021
Q4 		$1.36M Buy
+6,498
New +$1.34M 0.85% 36

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Agate Pass Investment Management's MED Position: Q2 2023 in Review

Agate Pass Investment Management sold out of Medifast (MED) in Q2 2023, closing a stake of 7,094 shares — an estimated $735K sold.

Agate Pass Investment Management first reported a position in MED in Q4 2021 and held it in 6 quarters. The position peaked at $1.36M in Q4 2021. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

  • Agate Pass Investment Management reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
  • Agate Pass Investment Management sold 7,094 Medifast shares in Q2 2023, an estimated $735K.
  • Agate Pass Investment Management first reported a position in Medifast in Q4 2021 and held it in 6 quarters.
  • Agate Pass Investment Management's Medifast position peaked at $1.36M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Agate Pass Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.